Literature DB >> 15048680

A review of thyroid cancer with intermediate differentiation.

Mark Sywak1, Janice L Pasieka, Travis Ogilvie.   

Abstract

BACKGROUND AND OBJECTIVES: Tall cell (TCV), columnar cell (CCV), insular (IC), diffuse sclerosing (DSPTC) and solid/trabecular are uncommon subtypes of thyroid cancer, which have generally been described in case reports or small series in the world literature. Due to the rarity of these thyroid cancers, their clinical behavior remains incompletely understood. The aim of this review was to pool the currently available clinical information regarding these uncommon thyroid cancers so as to gain a better understanding of their clinical aspects and natural history.
METHODS: A computer-aided search of MEDLINE (1966-2001, PUBMED website) and CINAHL (1982-2001) databases was performed, as well as a review of the reference section of each primary study was done. All cases of TCV, CCV, DSPTC, solid/trabecular, and IC described in the English medical literature were identified. For the subtypes DSPTC, TCV, and IC, clinical data from the published case series were combined in a weighted analysis. Weighting was based on the number of cases per series. For the CCV and the solid/trabecular variant, due to the small number of cases, raw figures for the clinical features were obtained.
RESULTS: DSPTC (n = 65) appeared to have a tendency for intra-thyroidal extension (40%) and a high propensity for nodal metastates (68%). The mean overall tumor related mortality was similar to well differentiated thyroid cancer (WDTC) at only 2% at 8 years follow-up. The solid/trabecular variant was seen in 37% of the radiation induced thyroid tumors of the Chernobyl accident. It had a high propensity for extrathyroidal extension, and cervical lymph node metastases were found in up to 83% of patients. Unlike WDTC, TCV (n = 209) was a more aggressive tumor, associated with distant metastases in 22% of cases and had a mean tumor related mortality of 16%. The histological diagnosis of TCV was a poor prognostic factor regardless of patient age or tumor size. The CCV (n = 41) had a high overall mortality rate of 32%. When encapsulated, however, CCV had an excellent prognosis similar to that found in WDTC. In contrast, CCV tumors that were not encapsulated had extrathyroidal spread in 67% and had distant metastases in 87% of patients. The variant of IC (n = 213) appeared to be an aggressive subtype of thyroid cancer. The mean loco-regional recurrence and/or distant metastases rate was 64% and tumor related mortality was high at 32%.
CONCLUSIONS: DSPTC, TCV, CCV, and IC are thyroid cancer subtypes, which have a biological aggressiveness, which appear to be intermediate between that of WDTC and poorly differentiated anaplastic thyroid cancer. J. Surg. Oncol. 2004;86:44-54. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15048680     DOI: 10.1002/jso.20044

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  23 in total

Review 1.  Exploiting biology in selecting treatment for differentiated cancer of the thyroid gland.

Authors:  Jatin P Shah
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-11       Impact factor: 2.503

2.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

3.  Solid variant of papillary thyroid carcinoma in a 14-year-old girl.

Authors:  Wan Faiziah Wan Abdul Rahman; Mohd Nizam Md Hashim; Thin Thin Win; Ikmal Hisyam Bakrin
Journal:  BMJ Case Rep       Date:  2013-06-06

4.  Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.

Authors:  Junko Akaishi; Tetsuo Kondo; Kiminori Sugino; Yuna Ogimi; Chie Masaki; Kiyomi Y Hames; Tomonori Yabuta; Chisato Tomoda; Akifumi Suzuki; Kenichi Matsuzu; Takashi Uruno; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Ryohei Katoh; Koichi Ito
Journal:  World J Surg       Date:  2019-09       Impact factor: 3.352

5.  Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.

Authors:  Iwao Sugitani; Kazuhisa Toda; Noriko Yamamoto; Atsuhiko Sakamoto; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

6.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

Review 7.  Changing management in patients with papillary thyroid cancer.

Authors:  Dina M Elaraj; Orlo H Clark
Journal:  Curr Treat Options Oncol       Date:  2007-08

Review 8.  Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer?

Authors:  Tobias Carling; Idris T Ocal; Robert Udelsman
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

9.  Completion lobectomy and central compartment dissection in low-risk patients who had undergone less extensive surgery than hemithyroidectomy.

Authors:  Wen-Bin Yu; Yun-Tao Song; Nai-Song Zhang
Journal:  Oncol Lett       Date:  2012-12-28       Impact factor: 2.967

10.  Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.

Authors:  Mijin Kim; Sun Wook Cho; Young Joo Park; Hwa Young Ahn; Hee Sung Kim; Yong Joon Suh; Dughyun Choi; Bu Kyung Kim; Go Eun Yang; Il-Seok Park; Ka Hee Yi; Chan Kwon Jung; Bo Hyun Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.